CopyFind
Levroxa 100mg Injection
medicine 📍 IN

Levroxa 100mg Injection

119,56 ₹

Analogs of Levroxa 100mg Injection

Find cheaper analogs and generic equivalents for Levroxa 100mg Injection.

Ingredients

活性成分: Levetiracetam


产品概览

About Levroxa

Levroxa is a medication containing the active ingredient Levetiracetam, classified as Medication. Levetiracetam, sold under the brand name Keppra among others, is an anti-seizure medication (medication) used to treat epilepsy. It is used for partial-onset, myoclonic, or tonic–clonic seizures, and is taken either by mouth as an immediate or extended release formulation or by injection into a vein.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1
  • Used for: 1) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile.
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Levetiracetam, the active ingredient in Levroxa, belongs to the Medication class. 1 INDICATIONS AND USAGE Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1. 1) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Levroxa. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Levroxa for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Levroxa 100mg Injection.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.